Evidence was searched in the Cochrane Central Register of Controlled Trials (CENTRAL,
The Cochrane Library April 2022, Issue 4), MEDLINE and EMBASE up to April 2022, with …

Background As part of its mission to improve the quality of care for women with
gynecological cancers across Europe, the European Society of Gynaecological Oncology …

Objective The aim of this study was to develop clinically relevant and evidence-based
guidelines as part of European Society of Gynaecological Oncology's mission to improve the …

The purpose of this guideline is to collate evidence and propose evidence-based guidelines
for the diagnosis and management of adult patients with vulva carcinoma treated in the UK …

Purpose: This is an official guideline, published and coordinated by the Arbeitsgemeinschaft
Gynäkologische Onkologie (AGO, Study Group for Gynecologic Oncology) of the Deutsche …

Objective This guideline reviews the clinical evaluation and management of squamous cell
cancer (SCC) of the vulva with respect to diagnosis, primary surgical, radiation, or …

Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are
predominantly squamous cell carcinomas (SCCs), which can arise through human …

Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority
are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of …

Background Vulvar cancer and vaginal cancer are relatively rare tumors, and there had
been no established treatment principles or guidelines to treat these rare tumors in Japan …

This review provides guidelines and aims to estimate utilisation rates of treatment modalities
applied in vulvar cancer. Current standards of treatment are as follows: wide local excision …